The Clinical & Translational Science Institute (CTSI) facilitates clinical and translational research to improve patient and community health. We do this by providing infrastructure, services, and training to enable research to be conducted more efficiently and effectively, and in new ways.
To advance our mission, we develop broad coalitions and partnerships at the local, regional and national levels to enable a transformation of the research environment.
Spotlight
Celebrating 20 Years of CTSI
We are excited to mark the 20th anniversary of CTSI by highlighting and celebrating the accomplishments of our outstanding program. Since 2006, CTSI has been steadfast in our mission to provide essential services, resources, infrastructure, and training to accelerate innovative clinical translation.
As we enter our third decade, we reflect on the transformative impact of CTSI programs including:
- UCSF Profiles, searched by 965,000 people annually and cited by all major media outlets.
- The Research Allocation Program (RAP), created at CTSI, now serves as the central infrastructure for 30 intramural grant mechanisms.
- The K Scholars Program, research training and professional development for 70 early-career faculty each year to ensure success for the next generation of research leaders.
- Community-based participatory research, key collaborations with community-based organizations throughout the Bay Area.
- APex-Enabled Research (AER), Apex modifications and enhancements for research.
- EHR-based Participant Recruitment, automated identification, contact, and tracking of eligible study participants.
- Clinical Research Service and Biospecimen Processing Lab, supporting 300 clinical research protocols per year across 6 clinical sites and the largest UCSF biobank.
The continued success of CTSI is driven by the talent, creativity, and commitment of our program staff, and faculty, and leadership.
Disparities in Diabetes Outcomes Panel Discussion
May 6, 2026, 12:10 PM - 1:00 PM | Zoom
This CTSI Celebrates panel discussion will focus on disparities in diabetes outcomes, successful interventions for addressing these challenges, how GLP-1 receptor agonist medications are changing care, and much more.
Speakers:
Elena Flowers, PhD, RN, Professor, Physiological Nursing
Meghana Gadgil, MD, Associate Professor, Medicine
Shylaja Srinivasan, MD, Associate Professor, Pediatrics